Cisplatin for cancer therapy and overcoming chemoresistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cisplatin for cancer therapy and overcoming chemoresistance

Published:2022-09 Issue:9 Volume:8 Page:e10608
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Ranasinghe Ranmali^ORCID,Mathai Michael L.,Zulli Anthony

Funder

Australian Government

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference206 articles.

1. Cisplatin in cancer therapy: molecular mechanisms of action;Dasari;Eur. J. Pharmacol.,2014

2. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy;Tchounwou;J. Exp. Pharmacol.,2021

3. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

4. MiR-155 inhibitor-laden exosomes reverse resistance to cisplatin in a 3D tumor spheroid and xenograft model of oral cancer;Sayyed;Mol. Pharm.,2021

5. Oncolytic HSV therapy modulates vesicular trafficking inducing cisplatin sensitivity and antitumor immunity;Hong;Clin. Cancer Res.,2021

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin Encapsulated Plasmonic Blackbodies for NIR Light Activatable Chemo‐Phototherapy and Reduction of 4‐Nitrophenol;Chemistry – An Asian Journal;2024-09-06

2. Data-Driven Modelling of Substituted Pyrimidine and Uracil-Based Derivatives Validated with Newly Synthesized and Antiproliferative Evaluated Compounds;International Journal of Molecular Sciences;2024-08-29

3. Remote organ cancer adversely alters renal function and induces kidney injury, inflammation, and fibrosis;2024-07-30

4. Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer;Cancers;2024-07-15

5. Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship;International Journal of Molecular Sciences;2024-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3